Actively Recruiting
Study of Modified Diagnosis and Treatment with ETCOc for Newborns with Severe Neonatal Hyperbilirubinemia
Led by Women's Hospital School Of Medicine Zhejiang University · Updated on 2026-01-20
250
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate if a modified diagnosis and treatment MDT approach combined with ETCOc measurement, a non-invasive test of exhaled gas, can prevent brain damage in newborns with severe neonatal hyperbilirubinemia sNH, a common cause of newborn jaundice. The study compares MDT to the current standard management to see which method better prevents brain injury before age one. It also monitors the frequency of abnormalities found in cranial MRI scans during this period. Participants will be randomly assigned to either the MDT group or the control group receiving the current management. MDT diagnoses neonatal hemolysis using specific criteria such as positive Direct Antiglobulin Test DAT, elevated ETCOc, or blood test markers, and applies exchange transfusion therapy according to defined bilirubin thresholds and neurological signs. The control group follows standard diagnosis and treatment methods based on DAT or release test results and bilirubin levels. Treatments will be administered during the newborn period according to these protocols. Throughout the study, participants will be assessed for brain damage at hospital discharge and again at one year using professional evaluations like the Bayley Scales. Researchers will record MRI abnormalities occurring before age one. The main outcome measured is neural damage confirmed at 12 months. The study starts in 2025 and continues through 2027, with participants monitored closely during the newborn period and followed up to one year of age.
CONDITIONS
Brief Title
Modified Diagnosis and Treatment of Neonatal Hemolysis With ETCOc in sNH
Research Team
Y
YIngying B
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here